Srividya Ramachandran, Ph.D. - Publications

Affiliations: 
2010 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Immunology, Virology Biology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Treat BR, Bidula SM, Ramachandran S, St Leger AJ, Hendricks RL, Kinchington PR. Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells. Plos Pathogens. 13: e1006732. PMID 29206240 DOI: 10.1371/Journal.Ppat.1006732  0.554
2013 Ramachandran S, Knickelbein JE, Ferko C, Hendricks RL, Kinchington PR. Corrigendum to "Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters" [Virology 378 (2008) 254-264] Virology. 435: 504. DOI: 10.1016/J.Virol.2012.10.014  0.538
2010 Ramachandran S, Davoli KA, Yee MB, Hendricks RL, Kinchington PR. Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion. Journal of Virology. 84: 8811-20. PMID 20573821 DOI: 10.1128/Jvi.00496-10  0.587
2008 Ramachandran S, Knickelbein JE, Ferko C, Hendricks RL, Kinchington PR. Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters. Virology. 378: 254-64. PMID 18619637 DOI: 10.1016/J.Virol.2008.05.034  0.585
2007 Ramachandran S, Kinchington PR. Potential prophylactic and therapeutic vaccines for HSV infections. Current Pharmaceutical Design. 13: 1965-73. PMID 17627530 DOI: 10.2174/138161207781039760  0.502
Show low-probability matches.